Bauer, M.A.; Todorova, V.K.; Stone, A.; Carter, W.; Plotkin, M.D.; Hsu, P.-C.; Wei, J.Y.; Su, J.L.; Makhoul, I.
Genome-Wide DNA Methylation Signatures Predict the Early Asymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer. Cancers 2021, 13, 6291.
https://doi.org/10.3390/cancers13246291
AMA Style
Bauer MA, Todorova VK, Stone A, Carter W, Plotkin MD, Hsu P-C, Wei JY, Su JL, Makhoul I.
Genome-Wide DNA Methylation Signatures Predict the Early Asymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer. Cancers. 2021; 13(24):6291.
https://doi.org/10.3390/cancers13246291
Chicago/Turabian Style
Bauer, Michael A., Valentina K. Todorova, Annjanette Stone, Weleetka Carter, Matthew D. Plotkin, Ping-Ching Hsu, Jeanne Y. Wei, Joseph L. Su, and Issam Makhoul.
2021. "Genome-Wide DNA Methylation Signatures Predict the Early Asymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer" Cancers 13, no. 24: 6291.
https://doi.org/10.3390/cancers13246291
APA Style
Bauer, M. A., Todorova, V. K., Stone, A., Carter, W., Plotkin, M. D., Hsu, P.-C., Wei, J. Y., Su, J. L., & Makhoul, I.
(2021). Genome-Wide DNA Methylation Signatures Predict the Early Asymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer. Cancers, 13(24), 6291.
https://doi.org/10.3390/cancers13246291